Press release
Non-invasive Prenatal Testing Market worth $16.05 billion by 2030, growing at a CAGR of 13.79% - Exclusive Report by 360iResearch
The "Non-invasive Prenatal Testing Market by Product (Consumables, Instruments), Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests), Application, End User - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/non-invasive-prenatal-testing?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Non-invasive Prenatal Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits & Reagents and Disposables. The Instruments is further studied across Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, and Ultrasound Devices. The Consumables is projected to witness significant market share during forecast period.
Based on Method, market is studied across Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests, and Ultrasound Detection. The Fetal Cells in Maternal Blood Tests is projected to witness significant market share during forecast period.
Based on Application, market is studied across Microdeletion Syndrome and Trisomy. The Microdeletion Syndrome is projected to witness significant market share during forecast period.
Based on End User, market is studied across Diagnostic Laboratories and Hospitals. The Diagnostic Laboratories is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Non-invasive Prenatal Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Non-invasive Prenatal Testing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Non-invasive Prenatal Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, BillionToOne, Inc., Biora Therapeutics, Inc., Eurofins LifeCodexx AG, Hoffmann-La Roche Ltd., Igenomix, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health PLC.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Non-invasive Prenatal Testing Market, by Product
7. Non-invasive Prenatal Testing Market, by Method
8. Non-invasive Prenatal Testing Market, by Application
9. Non-invasive Prenatal Testing Market, by End User
10. Americas Non-invasive Prenatal Testing Market
11. Asia-Pacific Non-invasive Prenatal Testing Market
12. Europe, Middle East & Africa Non-invasive Prenatal Testing Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Non-invasive Prenatal Testing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Non-invasive Prenatal Testing Market?
3. What is the competitive strategic window for opportunities in the Non-invasive Prenatal Testing Market?
4. What are the technology trends and regulatory frameworks in the Non-invasive Prenatal Testing Market?
5. What is the market share of the leading vendors in the Non-invasive Prenatal Testing Market?
6. What modes and strategic moves are considered suitable for entering the Non-invasive Prenatal Testing Market?
Read More @ https://www.360iresearch.com/library/intelligence/non-invasive-prenatal-testing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-invasive Prenatal Testing Market worth $16.05 billion by 2030, growing at a CAGR of 13.79% - Exclusive Report by 360iResearch here
News-ID: 3230683 • Views: …
More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…

The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…

The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…

The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Prenatal
Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview
The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT…
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia.
The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming…
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to…
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview
Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening.
Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html
The global prenatal diagnostics market is segmented on…
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction
Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027.
Overview
Rise in prevalence of chronic conditions, such as cancer and diabetes,…
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview
Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.…